Age- and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review

Table 2 Weighted mean region-specific HBsAg prevalence in blood donors and hospital settings

Study group					%HBsAg prevalence (range)
Category	no.studies	N	n	Region*	Weighted mean all data	Weighted mean published data	Pvalue	References
Blood donors	13	658662	16788	A	2.53 (1.10, 8.70)	2.33 (1.70, 2.75)	0.51	[34–40] (i-n)
	16	223949	6389	B	2.68 (1.70, 4.22)	3.44 (2.60, 4.20)	0.14	[41–46] (o-x)
	4	149918	6675	C	4.25 (1.70, 4.90)	4.45 (2.92, 4.90)	0.50	[47–49] (y)
Hospital†	5	37497	2977	A	3.40 (1.30, 13.80)	1.30 (0.90, 1.63)	0.40	[50] (z-cc)
	6	100343	7781	B	7.15 (2.90, 13.60)	5.73 (2.90, 13.60)	1.00	[51, 52] (dd-gg)
	2	28392	6037	C	-	10.88 (9.60, 21.30)	-	[53, 54]

Abbreviations: N number of subjects, n number of cases
P value calculated by the two-sided Mann-Whitney test (difference in prevalence of all data and only published data)
* Region A: Marmara and Aegean, B: Black Sea, Central Anatolia and Mediterranean, C: Eastern and South-eastern
† Studies based in hospital settings on non-liver-related conditions

ISSN: 1471-2334